RE:RE:RE:NBF report is out People looking at the transcript, what was the comment Paul made at the end of the call about investor engagement and bringing on new investors (I assumed he was talking about Soleus there)?
Wino115 wrote: BTW, on of THE KEY issues here is that they are not being covered by biotech analysts or oncology analysts. At this point it's only two middling "healthcare" guys which really doesn't amount to much for Canadian analysts and one NASH only analyst. The really need to lean on the Soleus guys (& whomever else bought in to that OO) to ask them to introduce them around to the actual Wall St biotech and oncology analysts that are important and beg them to cover them. I can't imagine Soleus is all that happy with the silent tree falling either.